Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The Value of an Automated Ultrasound System in the Detection of Synovitis.

Mueller R, Grunke M, Wendler J, Schuch F, Hofmann-Preiss K, Boettger I, Jakobs R, Schulze-Koops H, von Kempis J.

Ultrasound Int Open. 2018 Apr;4(2):E61-E68. doi: 10.1055/a-0612-7852. Epub 2018 Jul 11.

2.

Pupillary autonomic dysfunction in patients with ANCA-associated vasculitis.

Moog P, Eren O, Kossegg S, Valda K, Straube A, Grünke M, Schulze-Koops H, Witt M.

Clin Auton Res. 2017 Dec;27(6):385-392. doi: 10.1007/s10286-017-0463-1. Epub 2017 Sep 1.

PMID:
28864843
3.

[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].

Proft F, Schulze-Koops H, Grunke M, Schrezenmeier E, Halleck F, Henes J, Unger L, Schmidt E, Fiehn C, Jacobi A, Iking-Konert C, Kneitz C, Schmidt RE, Bannert B, Voll RE, Fischer-Betz R, Kötter I, Tony HP, Holle J, Aringer M, Erler A, Behrens F, Burmester GR, Dörner T.

Z Rheumatol. 2018 Feb;77(1):28-39. doi: 10.1007/s00393-017-0330-4. German.

PMID:
28589389
4.

[Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)].

Henes JC, Schulze-Koops H, Witt M, Tony HP, Mueller F, Grunke M, Czihal M, Dörner T, Proft F.

Z Rheumatol. 2018 Feb;77(1):12-20. doi: 10.1007/s00393-017-0325-1. German.

PMID:
28536934
5.

Evaluation of a Novel Semi-Automated Ultrasound System for the Detection of Synovitis: A Prospective Study involving 45 Patients with Rheumatoid Arthritis.

Witt M, Frielinghausen J, Mueller R, Mueller F, Proft F, Schulze-Koops H, Grunke M, Clevert DA.

Ultrasound Int Open. 2016 Nov;2(4):E117-E123. Epub 2016 Sep 14.

6.

Erratum to: The influence of long distance running on sonographic joint and tendon pathology: results from a prospective study with marathon runners.

Proft F, Grunke M, Reindl C, Schramm MA, Mueller F, Kriegmair M, Leipe J, Weinert P, Schulze-Koops H, Witt M.

BMC Musculoskelet Disord. 2016 Sep 2;17(1):381. No abstract available.

7.

The influence of long distance running on sonographic joint and tendon pathology: results from a prospective study with marathon runners.

Proft F, Grunke M, Reindl C, Schramm MA, Mueller F, Kriegmair M, Leipe J, Weinert P, Schulze-Koops H, Witt M.

BMC Musculoskelet Disord. 2016 Jul 11;17:272. doi: 10.1186/s12891-016-1121-9. Erratum in: BMC Musculoskelet Disord. 2016 Sep 2;17 (1):381.

8.

Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis.

Moog P, Eren O, Witt M, Rauschel V, Kossegg S, Straube A, Grünke M, Schulze-Koops H.

Clin Auton Res. 2016 Aug;26(4):279-85. doi: 10.1007/s10286-016-0364-8. Epub 2016 Jul 1.

PMID:
27364144
9.

Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener's).

Proft F, Steinbach S, Dechant C, Witt M, Reindl C, Schulz S, Vielhauer V, Hilge R, Laubender RP, Manger K, Nüsslein H, Wendler J, Schuch F, Schulze-Koops H, Grunke M.

Scand J Rheumatol. 2014;43(6):512-8. doi: 10.3109/03009742.2014.915056. Epub 2014 Sep 10.

PMID:
25204208
10.

Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey.

Witt M, Meier J, Hammitzsch A, Proft F, Schulze-Koops H, Grunke M.

Semin Arthritis Rheum. 2014 Jun;43(6):745-50. doi: 10.1016/j.semarthrit.2013.10.010. Epub 2013 Oct 29.

PMID:
24816195
11.

Ultrasound of synovitis in rheumatoid arthritis: advantages of the dorsal over the palmar approach to finger joints.

Witt MN, Mueller F, Weinert P, Nigg AP, Reindl CS, Proft F, Schulze-Koops H, Grunke M.

J Rheumatol. 2014 Mar;41(3):422-8. doi: 10.3899/jrheum.131027. Epub 2014 Feb 1.

PMID:
24488415
12.

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony HP, Unger L, Wassenberg S, Dörner T, Schulze-Koops H; German Registry of Autoimmune Diseases (GRAID) Investigators.

Lupus. 2013 Oct;22(11):1142-9. doi: 10.1177/0961203313503912.

PMID:
24057058
13.

Automatic face classification of Cushing's syndrome in women - a novel screening approach.

Kosilek RP, Schopohl J, Grunke M, Reincke M, Dimopoulou C, Stalla GK, Würtz RP, Lammert A, Günther M, Schneider HJ.

Exp Clin Endocrinol Diabetes. 2013 Oct;121(9):561-4. doi: 10.1055/s-0033-1349124. Epub 2013 Jul 17.

PMID:
23864496
14.

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.

Baraliakos X, Heldmann F, Callhoff J, Listing J, Appelboom T, Brandt J, Van den Bosch F, Breban M, Burmester G, Dougados M, Emery P, Gaston H, Grunke M, Van Der Horst-Bruinsma IE, Landewé R, Leirisalo-Repo M, Sieper J, De Vlam K, Pappas D, Kiltz U, Van Der Heijde D, Braun J.

Ann Rheum Dis. 2014 Oct;73(10):1819-25. doi: 10.1136/annrheumdis-2013-203425. Epub 2013 Jul 14.

PMID:
23852807
15.

Relevance of grade 1 gray-scale ultrasound findings in wrists and small joints to the assessment of subclinical synovitis in rheumatoid arthritis.

Witt M, Mueller F, Nigg A, Reindl C, Leipe J, Proft F, Stein N, Hammitzsch A, Mayer S, Dechant C, Schulze-Koops H, Grunke M.

Arthritis Rheum. 2013 Jul;65(7):1694-701. doi: 10.1002/art.37954.

16.

The proposed changes for DSM-5 for SLD and ADHD: international perspectives--Australia, Germany, Greece, India, Israel, Italy, Spain, Taiwan, United Kingdom, and United States.

Al-Yagon M, Cavendish W, Cornoldi C, Fawcett AJ, Grünke M, Hung LY, Jiménez JE, Karande S, van Kraayenoord CE, Lucangeli D, Margalit M, Montague M, Sholapurwala R, Sideridis G, Tressoldi PE, Vio C.

J Learn Disabil. 2013 Jan-Feb;46(1):58-72. doi: 10.1177/0022219412464353. Review.

PMID:
23197670
17.

Use of the 28-joint count yields significantly higher concordance between different examiners than the 66/68-joint count.

Grunke M, Witt MN, Ronneberger M, Schnez A, Laubender RP, Engelbrecht M, Kavanaugh A, Schulze-Koops H.

J Rheumatol. 2012 Jul;39(7):1334-40. doi: 10.3899/jrheum.110677. Epub 2012 Jun 1.

PMID:
22660799
18.

[Biomarkers in rheumatology. Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research].

Häupl T, Appel H, Backhaus M, Burkhardt H, Grünke M, Grützkau A, Hoppe B, Listing J, Ostendorf B, Rudwaleit M, Sieper J, Skapenko A, Skriner K, Sörensen T, Stuhlmüller B, Zink A, Schulze-Koops H, Burmester GR.

Z Rheumatol. 2012 Jun;71(4):314-8. doi: 10.1007/s00393-011-0781-y. German.

PMID:
22546912
19.

[Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? No].

Grünke M.

Dtsch Med Wochenschr. 2011 Aug;136(33):1675. doi: 10.1055/s-0031-1281574. Epub 2011 Aug 10. German. No abstract available.

PMID:
21833890
20.

[46-year-old patient with [corrected] unknown systemic disease].

Kapser J, Grünke M.

Dtsch Med Wochenschr. 2011 Aug;136(33):1667-8. doi: 10.1055/s-0031-1281571. Epub 2011 Aug 10. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2012 Apr;137(14):699.

PMID:
21833887
21.

Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis.

Leipe J, Schramm MA, Grunke M, Baeuerle M, Dechant C, Nigg AP, Witt MN, Vielhauer V, Reindl CS, Schulze-Koops H, Skapenko A.

Ann Rheum Dis. 2011 Aug;70(8):1453-7. doi: 10.1136/ard.2011.152074. Epub 2011 May 18.

PMID:
21593004
22.

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Tony HP, Burmester G, Schulze-Koops H, Grunke M, Henes J, Kötter I, Haas J, Unger L, Lovric S, Haubitz M, Fischer-Betz R, Chehab G, Rubbert-Roth A, Specker C, Weinerth J, Holle J, Müller-Ladner U, König R, Fiehn C, Burgwinkel P, Budde K, Sörensen H, Meurer M, Aringer M, Kieseier B, Erfurt-Berge C, Sticherling M, Veelken R, Ziemann U, Strutz F, von Wussow P, Meier FM, Hunzelmann N, Schmidt E, Bergner R, Schwarting A, Eming R, Hertl M, Stadler R, Schwarz-Eywill M, Wassenberg S, Fleck M, Metzler C, Zettl U, Westphal J, Heitmann S, Herzog AL, Wiendl H, Jakob W, Schmidt E, Freivogel K, Dörner T; GRAID investigators.

Arthritis Res Ther. 2011 May 13;13(3):R75. doi: 10.1186/ar3337.

23.

[New biologics and orally available compounds. What is still in the pipeline?].

Grünke M, Bastian H, Schulze-Koops H, Burmester GR.

Z Rheumatol. 2010 Sep;69(7):626-32. doi: 10.1007/s00393-009-0531-6. Review. German.

PMID:
20725732
24.

[Quality of a multidisciplinary orthopaedic-rheumatological consultation].

Mayer-Wagner S, Wiendl F, Schewe S, Grünke M, Schulze-Koops H, Delhey P, Holzapfel BM, Jansson V, Hausdorf J.

Z Rheumatol. 2010 Oct;69(8):749-54. doi: 10.1007/s00393-010-0666-5. German.

PMID:
20632178
25.

Role of Th17 cells in human autoimmune arthritis.

Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, Skapenko A.

Arthritis Rheum. 2010 Oct;62(10):2876-85. doi: 10.1002/art.27622.

26.

Standardization of joint examination technique leads to a significant decrease in variability among different examiners.

Grunke M, Antoni CE, Kavanaugh A, Hildebrand V, Dechant C, Schett G, Manger B, Ronneberger M.

J Rheumatol. 2010 Apr;37(4):860-4. doi: 10.3899/jrheum.090195. Epub 2010 Feb 15.

PMID:
20156953
27.

Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.

Mueller MC, Fleischmann E, Grunke M, Schewe S, Bogner JR, Löscher T.

Am J Trop Med Hyg. 2009 Jul;81(1):52-4.

PMID:
19556566
28.

Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis.

Schildmann J, Grunke M, Kalden JR, Vollmann J.

J Med Ethics. 2008 Nov;34(11):775-9. doi: 10.1136/jme.2007.023705.

PMID:
18974408
29.

Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.

Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P.

Arthritis Rheum. 2008 Apr;58(4):976-84. doi: 10.1002/art.23385.

30.

Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade.

Grunke M, Schulze-Koops H.

Ann Rheum Dis. 2006 Apr;65(4):555-6. No abstract available.

31.

Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus.

Lorenz HM, Grunke M, Wendler J, Heinzel PA, Kalden JR.

Ann Rheum Dis. 2005 Oct;64(10):1517-9. No abstract available.

32.

Etanercept: an introduction.

Grunke M, Kalden JR.

Expert Rev Clin Immunol. 2005 Sep;1(3):313-23. doi: 10.1586/1744666X.1.3.313.

PMID:
20476983
33.

Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.

Mueller RB, Skapenko A, Grunke M, Wendler J, Stuhlmuller B, Kalden JR, Schulze-Koops H.

Arthritis Rheum. 2005 Feb;52(2):451-60.

34.

15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.

Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grünke M, Peter HH, Kalden JR, Göbel U, Drexler JM, Hotta O, Nowack R, Van Der Woude FJ.

J Am Soc Nephrol. 2003 Feb;14(2):440-7.

35.

Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy.

Cursiefen C, Grunke M, Dechant C, Antoni C, Jünemann A, Holbach LM.

Am J Ophthalmol. 2002 Aug;134(2):270-1.

PMID:
12140038
36.

Hyporesponsiveness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis.

Lorenz HM, Grünke M, Hieronymus T, Winkler S, Blank N, Rascu A, Wendler J, Geiler T, Kalden JR.

Eur J Immunol. 2002 May;32(5):1253-63.

37.

Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.

Van Vaerenbergh K, Harrer T, Schmit JC, Carbonez A, Fontaine E, Kurowski M, Grünke M, Löw P, Rascu A, Schmidt B, Schmitt M, Thoelen I, Walter H, Van Laethem K, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM.

AIDS Res Hum Retroviruses. 2002 Apr 10;18(6):419-26.

PMID:
11958685
38.

Chlorpromazine induces apoptosis in activated human lymphoblasts: a mechanism supporting the induction of drug-induced lupus erythematosus?

Hieronymus T, Grötsch P, Blank N, Grünke M, Capraru D, Geiler T, Winkler S, Kalden JR, Lorenz HM.

Arthritis Rheum. 2000 Sep;43(9):1994-2004.

39.

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.

Kasten S, Goldwich A, Schmitt M, Rascu A, Grunke M, Dechant C, Kalden JR, Harrer T.

Eur J Med Res. 2000 Aug 18;5(8):323-8.

PMID:
10958764
40.

In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.

Lorenz HM, Grünke M, Hieronymus T, Antoni C, Nüsslein H, Schaible TF, Manger B, Kalden JR.

J Rheumatol. 2000 Feb;27(2):304-10.

PMID:
10685789
41.

Hydroxyurea as part of a salvage regimen for heavily pretreated patients with advanced HIV infection.

Grunke M, Dechant C, Löw P, Rascu A, Kalden JR, Harrer T.

J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):424-6. No abstract available.

PMID:
10458626
42.

[An unusual case of Heberden arthrosis in a young man].

Rascu A, Kraetsch HG, Grünke M, Kalden JR, Manger B.

Z Rheumatol. 1999 Apr;58(2):95-9. German.

PMID:
10408070
43.

Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation.

Haas JP, Grunke M, Frank C, Kolowos W, Dirnecker D, Leipold G, Hieronymus T, Lorenz HM, Herrmann M.

Cell Death Differ. 1998 Sep;5(9):751-7.

44.

Nelfinavir associated with peripheral neuropathy in an HIV-infected patient.

Grunke M, Kraetsch HG, Löw P, Rascu A, Kalden JR, Harrer T.

Infection. 1998 Jul-Aug;26(4):252. No abstract available.

PMID:
9717687
45.

Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir.

Grunke M, Valerius T, Manger B, Kalden JR, Harrer T.

Clin Infect Dis. 1997 Nov;25(5):1270-1. No abstract available.

PMID:
9402412
46.

Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes.

Lorenz HM, Hieronymus T, Grünke M, Manger B, Kalden JR.

Scand J Immunol. 1997 Jun;45(6):660-9.

47.

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.

Arthritis Rheum. 1997 Feb;40(2):306-17.

PMID:
9041943
48.

In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.

Lorenz HM, Antoni C, Valerius T, Repp R, Grünke M, Schwerdtner N, Nüsslein H, Woody J, Kalden JR, Manger B.

J Immunol. 1996 Feb 15;156(4):1646-53.

PMID:
8568271
49.

A rapid and simple method for the isolation of apoptotic DNA fragments.

Herrmann M, Lorenz HM, Voll R, Grünke M, Woith W, Kalden JR.

Nucleic Acids Res. 1994 Dec 11;22(24):5506-7. No abstract available.

50.

[Symptomatic chylous prepatellar bursitis following lymphography].

Grünke M, Gerlach A, Kugler V.

Rofo. 1992 Dec;157(6):603-4. German. No abstract available.

PMID:
1457801

Supplemental Content

Loading ...
Support Center